References

1. Johnston SA: Osteoarthritis Joint anatomy, physiology and pathobiology. Vet Clin North Am Small Anim Pract 27(4): 703-705, 1997.
2. Deal CL, Moskowitz RW: Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamin, echondroitin sulphate and collagen hydrolysate. Rheum Dis North Am 25(2): 379-395, 1999.
3. Ronca F, Palmieri L, Panicucci P, Ronca G: Anti-inflammatory activity of chondroitin sulphate. Osteoarth Cartil 6(SupplA):14 21,1998.
4. Pipitone VR: Chondroprotection with chondroitin sulphate, Drugs Exp Clin Res 18:3-7, 1991.
5. Usha PR, Naidu MU, Ra ndomised, Double-Blind, Parallel, Placebo-Controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthristis. Clin Drug lnvestig, 2004; 24(6): 353-63.
6. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF: Efficacy of methylsulfonylmethane in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarth Cartil 2006 Mar; 14(3): 286-94.
7. Report on assaying of mussel extracts. P.Davis, Bioactivity Investigation group, Wellington School of Medicine, Otago University. Nov 2001.
8. A Novel anti-inflammatory glycogen extract from Mussels. Dr George Slim, Industrial Research Ltd.
9. Harris ED, Budd RC, Firestein GS, et al. Structure and Function of Bone, Joints and Connective Tissue. Kelley’s Textbook of Rheumatology. 7th ed, 2005.
10. Trinity Bioactives Ltd (TBL). 2009 Project NZC-AROM-3309 The Effect of Samples on Neutrophil Superoxide Production. Report on file at Kyron Laboratorie. s